DAX24.992 -1,1%Est506.114 -0,3%MSCI World4.343 -0,1%Top 10 Crypto8,2400 -4,6%Nas22.609 -1,2%Bitcoin54.887 -4,0%Euro1,1800 ±0,0%Öl71,31 -0,5%Gold5.213 +2,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Novo Nordisk A3EU6F Rheinmetall 703000 SAP 716460 NVIDIA 918422 Bayer BAY001 Deutsche Telekom 555750 Siemens Energy ENER6Y Microsoft 870747 Lufthansa 823212 Infineon 623100 Amazon 906866 Allianz 840400 DEUTZ 630500 BASF BASF11 Mercedes-Benz Group (ex Daimler) 710000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen rot -- DAX letztlich unter 25.000 Punkten -- Trump will Zollsatz weiter erhöhen -- Novo Nordisk-Studie enttäuscht -- DroneShield, Bayer, Diginex, Rüstungsaktien, NVIDIA, SAP, VW im Fokus
Top News
Milliarden-Vergleich und US-Garantie: So steht es um die Bayer-Aktie Milliarden-Vergleich und US-Garantie: So steht es um die Bayer-Aktie
Carmignac Sécurité: Flexibilität und Stabilität im europäischen Rentenmarkt Carmignac Sécurité: Flexibilität und Stabilität im europäischen Rentenmarkt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Metalsource Mining bringt sich als Key Player im Explorersektor in Stellung - und steht genau jetzt an einem Wendepunkt.
Wer­bung

AstraZeneca Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
173,85 EUR +0,20 EUR +0,12 %
STU
205,20 USD +1,00 USD +0,49 %
NYSE
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.270,64 Mrd. EUR

KGV27,55Div. Rendite1,71%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN886455

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINGB0009895292

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolAZN

AstraZeneca Aktien News

DatumMeistgelesen
PR NewswireTurbine Launches Collaboration with AstraZeneca, Leveraging Turbine's Virtual Disease Models to Rationalize ADC Discovery
PR NewswireSOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
PR NewswireSOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
Wer­bungAstraZeneca-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireSOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
PR NewswireSOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
PR NewswireThe Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact
PR NewswireAlexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (N...
PR NewswireAlexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (N...
PR NewswireSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
PR NewswireSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
PR NewswireSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
PR NewswireSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
PR NewswireDanaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireIgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals
PR NewswireLeading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
PR NewswireFinal Deadline for the AstraZeneca PLC Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - AZN
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN
PR NewswireShareholders that lost money on AstraZeneca PLC(AZN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
PR NewswireAstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswireThe Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline - AZN
PR NewswireSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Ag...
PR NewswireAZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAZN Investors have Opportunity to Lead AstraZeneca PLC Securities Fraud lawsuit
PR NewswireRosen Law Firm Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
PR NewswireGRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

AstraZeneca News

AstraZeneca News: auf dieser Seite finden Sie alle AstraZeneca News und Nachrichten zur AstraZeneca Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AstraZeneca News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AstraZeneca News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.